Answers are grounded in this paper and cite their sources.
Recent research has utilized clinical data collected over time to develop various predictive models for identifying diseases. Depending on a person's present state of health, machine learning models can find and diagnose a wide range of diseases at an early stage. However, disease forecasting still faces limitations, such as inadequate large-scale data, challenges in feature selection, and the complex structure of the models. This research introduces an innovative approach to address these issues with a multi-disease prediction model that retrieves datasets from the UCI collection, including chronic kidney disease, lung cancer, cervical cancer, Parkinson's disease, and HCC survival. The initial stage involves gathering diverse medical datasets from several reputable sources. After obtaining a set of characteristics, the optimal feature selection technique is performed using a combination of two meta-heuristic algorithms: the Salp Swarm Algorithm (SSA) and the Tuna Swarm Optimization (TSO) Algorithm. This SSATSO algorithm was specifically architected for this purpose, by combining the robust global exploration capabilities of the Salp Swarm Algorithm with the intensive local exploitation analysis of the Tuna Swarm Optimization. This dual-mechanism approach enables the algorithm to effectively traverse the complex, multi-modal search space of potential feature combinations, avoiding local optima and converging on a subset that optimally contributes to predictive accuracy. The SSATSO algorithm functions as an intelligent, adaptive filter, proactively shielding the subsequent C-SBiLSTM classifier from the detrimental effects of the curse of dimensionality. This enables the deep learning network to allocate its representational capacity exclusively to learning the complex, non-linear relationships within the most salient features, resulting in a model that is not only more accurate but also more robust and generalizable. It is important to highlight that while other standard models also exhibit some improvement with feature reduction, the proposed framework demonstrates a high-performance gradient and consistently secures the top accuracy across all subset sizes, highlighting the superior efficacy of the hybrid SSATSO approach. The proposed SSATSO C-SBiLSTM framework's demonstrates clear superiority across the comprehensive suite of performance metrics, such as accuracy, precision, recall, f-score, and specificity consistently replicated across five distinct and complex disease domains, validating the framework not only in a specialized solution for a single condition, but also highly reliable platform for computational clinical decision support.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: